Scarica l'app Stockscreener
0.7506
1.24%
-0.0094
Precedente Chiudi:
$0.76
Aprire:
$0.77
Volume 24 ore:
27,976
Relative Volume:
0.17
Capitalizzazione di mercato:
$11.20M
Reddito:
$4.03M
Utile/perdita netta:
$24.32M
Rapporto P/E:
-0.1745
EPS:
-4.3008
Flusso di cassa netto:
$-45.76M
1 W Prestazione:
+14.58%
1M Prestazione:
+0.08%
6M Prestazione:
-32.38%
1 anno Prestazione:
-56.36%
Intervallo 1D:
$0.7212
$0.77
Intervallo di 1 settimana:
$0.64
$0.7999
Portata 52W:
$0.55
$2.4299
Pavmed Inc Stock (PAVM) Company Profile
Nome
Pavmed Inc
Settore
Industria
Telefono
(212) 949-4319
Indirizzo
360 MADISON AVENUE, NEW YORK, NY
Confronta PAVM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
0.7212 | 11.20M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
129.37 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
101.95 | 138.41B | 17.55B | 2.03B | 2.37B | 1.37 |
|
SYK
Stryker Corp
|
365.59 | 129.62B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.74 | 107.92B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.28 | 40.53B | 5.54B | 4.18B | 259.90M | 7.00 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-03-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-11-05 | Iniziato | Ascendiant Capital Markets | Buy |
| 2018-06-28 | Iniziato | Maxim Group | Buy |
Pavmed Inc Borsa (PAVM) Ultime notizie
PAVmed switches to new accounting firm post-acquisition - Investing.com Australia
PAVmed switches to new accounting firm post-acquisition By Investing.com - Investing.com South Africa
PAVmed, Lucid post encouraging results from EsoGuard study (LUCD:NASDAQ) - Seeking Alpha
NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD - StreetInsider
Breakthrough: NCI Study Validates EsoGuard's Perfect Accuracy for Early Cancer Detection$60B Market Impact - Stock Titan
PAVmed Files Prospectus Relates To Potential Offer, Sale From Time To Time Of 3.3 Million Shares Of Common Stock By Selling Stockholders - marketscreener.com
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume - ADVFN
PAVmed Provides Business Update and Second Quarter 2024 Financial Results - ADVFN
Lucid Diagnostics finalizes public offering of common stock - Medical Buyer
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - The Bradford Era
Lucid Diagnostics Closes $16.1 Million Public Offering - MSN
PAVmed (PAVM) Stock Price, News & Analysis - MarketBeat
PAVmed subsidiary completes $16.1M stock offering By Investing.com - Investing.com Canada
PAVmed subsidiary completes $16.1M stock offering - Investing.com Australia
Lucid Diagnostics completes $16.1 million stock offering By Investing.com - Investing.com South Africa
Lucid Diagnostics Raises $16.1 Mln Through Public Offering To Support Corporate Growth - Nasdaq
Lucid Diagnostics Announces Closing of Public Offering of Common Stock - GuruFocus
Lucid Diagnostics completes $16.1 million stock offering - Investing.com Australia
Indo-Asian News Service - Indo-Asian News Service (IANS)
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock (PR Newswire) - Aktiellt
Lucid Diagnostics Announces Proposed Public Offering of Common Stock - The Malaysian Reserve
Lucid Diagnostics announces proposed public offering of common stock - MSN
Medical Diagnostics Pioneer Lucid Secures $15M Strategic Financing Round - Stock Titan
Lucid Diagnostics plans stock offering to boost capital By Investing.com - Investing.com South Africa
Lucid Diagnostics Announces Proposed Public Offering of Common S - GuruFocus
SEC Form 424B5 filed by Lucid Diagnostics Inc. - Quantisnow
Lucid Diagnostics plans stock offering to boost capital - Investing.com Australia
Commercial-Stage Cancer Prevention Company Lucid Diagnostics Unveils Strategic Funding Move - Stock Titan
Indo-Asian News Service-LUCID DIAGNOSTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK - Indo-Asian News Service (IANS)
Indo-Asian News Service-LUCID DIAGNOSTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK - Indo-Asian News Service (IANS)
PAVmed (PAVM) Files to Sell 3.3 Million Shares - GuruFocus
Pavmed Inc Files For Offering Of 3.3 Million Shares Of Common Stock - marketscreener.com
PAVmed stock touches 52-week low at $0.56 amid market challenges By Investing.com - Investing.com South Africa
PAVmed stock touches 52-week low at $0.56 amid market challenges - Investing.com India
Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference - BioSpace
Lucid Diagnostics to Participate in Fireside Chat at the 24th An - GuruFocus
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
PAVmed outlines strategic milestones for 2025, including Veris implantable device submission - MSN
Pavmed’s Strategic Growth and Financial Challenges - MSN
PAVmed Inc. (NASDAQ:PAVM) Q4 2024 Earnings Call Transcript - Insider Monkey
Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology - PR Newswire
Game-Changing Cancer Detection: EsoCheck Achieves 99% Accuracy Across 30,000 Patient Study - Stock Titan
PAVmed Inc (PAVM) Q4 2024 Earnings Call Highlights: Strategic Growth and Financial Stability - Yahoo
PAVmed Inc (PAVM) Q4 2024 Earnings Call Highlights: Strategic Gr - GuruFocus.com
PAVmed Reports Strong Q4 Results and Strategic Progress - TipRanks
Pavmed Inc Azioni (PAVM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):